<amendment session="109" chamber="s" number="1379" updated="2022-02-03T05:35:44Z">
  <amends type="s" number="1042" sequence=""/>
  <status datetime="2005-11-04">withdrawn</status>
  <sponsor bioguide_id="D000563"/>
  <offered datetime="2005-07-21"/>
  <description>To require certain dietary supplement manufacturers to report certain serious adverse events.</description>
  <actions>
    <action datetime="2005-11-04">
      <text>Proposed amendment SA 1379 withdrawn in Senate.</text>
    </action>
    <action datetime="2005-11-04">
      <text>Measure laid before Senate by unanimous consent.</text>
      <reference ref="CR S12377" label="consideration"/>
    </action>
    <action datetime="2005-07-26">
      <text>Considered by Senate.</text>
      <reference ref="CR S8897" label="consideration"/>
    </action>
    <action datetime="2005-07-25">
      <text>Considered by Senate.</text>
      <reference ref="CR S8772" label="consideration"/>
    </action>
    <action datetime="2005-07-22">
      <text>Considered by Senate.</text>
      <reference ref="CR S8717" label="consideration"/>
    </action>
    <action datetime="2005-07-21">
      <text>Amendment SA 1379 proposed by Senator Durbin. (consideration: CR S8635-8638; text: CR S8635) To require certain dietary supplement manufacturers to report certain serious adverse events.</text>
    </action>
    <action datetime="2005-07-21">
      <text>Senate amendment proposed (on the floor): Amendment SA 1379 proposed by Senator Durbin.</text>
      <reference ref="CR S8635-8638" label="consideration"/>
      <reference ref="CR S8635" label="text"/>
    </action>
    <action datetime="2005-07-21">
      <text>Senate amendment submitted</text>
    </action>
  </actions>
</amendment>
